Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly targeting PDE10A for potential treatment of neurological disorders such as schizophrenia and Huntington’s disease. Its structure supports high selectivity and binding affinity to target enzymes, making it valuable in developing central nervous system-acting drugs. Also explored in medicinal chemistry for optimizing bioavailability and metabolic stability in preclinical drug candidates.